Case report: CAR-T therapy demonstrated safety and efficacy in relapsed/refractory diffuse large B-cell lymphoma patients complicated with hepatitis B-related cirrhosis

Case report: CAR-T therapy demonstrated safety and efficacy in relapsed/refractory diffuse large B-cell lymphoma patients complicated with hepatitis B-related cirrhosis

Chimeric antigen receptor T-cell (CAR-T) therapy has demonstrated both efficacy and safety in relapsed/refractory diffuse large B-cell lymphoma (DLBCL) patients infected with hepatitis B virus (HBV). However, its applicability in individuals with liver cirrhosis remains largely unexplored due to the...

Full description

Saved in:
Bibliographic Details
Main Authors: Danqing Kong, Nana Ping, Qian Zhu, Xiao Zhang, Junhong Li, Rui Zou, Depei Wu, Zhengming Jin, Changju Qu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Oncology
Subjects:
diffuse large B-cell lymphoma
cirrhosis
chimeric antigen receptor T-cell therapy
hepatitis B virus
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1491100/full
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items